PMA device
Cartiva Synthetic Cartilage Implant (SCI)
Cartiva, Inc. · Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant (PNW, Class III) · First FDA decision Jul 1, 2016, newest Dec 10, 2021Foot and ankle conditions
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
6
Naming "Cartiva Synthetic"
MAUDE reports
19
Brand "Cartiva Synthetic", since 2015
PubMed studies
8
Mentioning "Cartiva Synthetic"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cartiva Synthetic Cartilage Implant (SCI)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Cartiva Synthetic Cartilage Implant (SCI)PMA supplement
P150017-S015 · Decided Dec 10, 2021 · 163 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, metatarsophalangeal joint cartilage replacement implant (PNW) · Orthopedic Surgery
- Cartiva Synthetic Cartilage Implant (Cartiva SCI)PMA supplement
P150017-S013 · Decided Feb 9, 2020 · 188 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, metatarsophalangeal joint cartilage replacement implant (PNW) · Orthopedic Surgery
- Cartiva Synthetic Cartilage ImplantPMA supplement
P150017-S011 · Decided Jul 12, 2019 · 178 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, metatarsophalangeal joint cartilage replacement implant (PNW) · Orthopedic Surgery
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
- Major Joint Replacement (Hip and Knee)Local determinationIn effectL33618First Coast Service Options, Inc.Updated Nov 21, 2019
- Lower Extremity Major Joint Replacement (Hip and Knee)Local determinationIn effectL36007Novitas Solutions, Inc.Updated Nov 8, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Cartiva Synthetic", any status and sponsor, newest update first.
University of Wisconsin, MadisonAcademic, hospital or other
NCT03935880 · 20 participants · Start Apr 15, 2019 · Primary completion Sep 27, 2021
Device: Cartiva Implant · For: Hallux Rigidus
Sites: Madison, Wisconsin
- Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis Compared to LRTI (GRIP 2)Status unknown
Cartiva, Inc.Not on our public-company list
NCT03247439 · 74 participants · Start Dec 22, 2017 · Primary completion Oct 30, 2020
Device: Cartiva · For: Osteoarthritis
Sites: San Diego, California; Atlanta, Georgia; Indianapolis, Indiana · 9 sites in all
University of OklahomaAcademic, hospital or other
NCT03489876 · 0 participants · Start Jan 1, 2019 · Primary completion Dec 2023
Device: Synthetic Cartilage Implant · For: Metatarsophalangeal Joint Arthritis
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cartiva Synthetic", and for the whole product code for context.
This brand
19 reports: 0 malfunction, 19 injury, 0 death
Whole product code PNW
594 reports: 20 malfunction, 574 injury, 0 death
Newest reports for this brand
3009351194-2022-00110 · Received Aug 31, 2022 · Event dated Aug 5, 2022
Device type: Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant (PNW)
Device problem as coded: Naturally Worn
Patient problem as coded: Failure of Implant; Implant Pain
3009351194-2022-00109 · Received Aug 19, 2022 · Event dated Aug 25, 2020
Device type: Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant (PNW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Nerve Damage; Loss of Range of Motion; Discomfort; Irritability; Implant Pain
3009351194-2022-00108 · Received Aug 16, 2022 · Event dated Jun 13, 2019
Device type: Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant (PNW)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Nerve Damage; Loss of Range of Motion; Discomfort; Irritability; Ambulation or Postural Difficulties; Implant Pain
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Cartiva Synthetic Cartilage Implant (SCI) Catalog: CAR-06-US (6mm), CAR-08-US (8mm), CAR-10-US (10mm), CAR-12-US (12mm)Open, Classified
Z-0598-2025 · Started Oct 31, 2024 · Posted by FDA Dec 4, 2024
Reason given: Patients implanted with synthetic cartilage implant, may experience a higher-than expected occurrence rate of the following hazards: revision, removal, implant subsidence, displacement, pain, nerve damage or fragmentation.
Cause as FDA categorized it: Device Design · Device type: Prosthesis, Metatarsophalangeal Joint Cartilage Replacement Implant (PNW)
Published research
The most relevant PubMed records for "Cartiva Synthetic"[tiab]. The summary above synthesizes these.
- Synthetic cartilage implant vs. first metatarsophalangeal arthrodesis for the treatment of hallux rigidus.
Budde K, Claassen L, Plaass C, et al. · Arch Orthop Trauma Surg · 2024Comparative Study
- Mid-term efficacy of the Cartiva synthetic cartilage implant in symptomatic hallux rigidus.
Fletcher WR, Collins T, Fox A, et al. · Bone Jt Open · 2024
- Cartiva case series: The efficacy of the cartiva synthetic cartilage implant interpositional arthroplasty at one year.
Brandao B, Aljawadi A, Hall A, et al. · J Orthop · 2020
- Comparing the efficacy of Cartiva synthetic cartilage implant hemiarthroplasty vs osteotomy for the treatment of conditions affecting the second metatarsal head.
Brandao B, Fox A, Pillai A · Foot (Edinb) · 2019Comparative Study
- Cartiva interpositional arthroplasty versus arthrodesis in the treatment of Hallux rigidus: A retrospective comparative study with mean 2 year follow up.
Lewis TL, Trowbridge S, Franklin S, et al. · Foot Ankle Surg · 2024Comparative Study
- Surgical management of first metatarsophalangeal joint osteoarthritis: The rise and fall of the Cartiva® synthetic cartilage implant.
Menz HB, Cotchett M, Munteanu SE, et al. · Osteoarthritis Cartilage · 2026Editorial
- Treatment of Hallux Rigidus: Comparison of Hemiarthroplasty with Cartiva Implant, Allograft Interpositional Arthroplasty, and Arthrodesis.
Sanii R, Phan K, Krumm D, et al. · Foot Ankle Orthop · 2025
- Cartiva or fusion for Hallux Rigidus? A systematic review and meta-analysis.
Jeremic A, Abussa R · J Foot Ankle Surg · 2026Systematic Review, Meta-Analysis
Other devices of this type
Also filed under product code PNW.
- Cartiva SCI reusable instrumentationCartiva, Inc. · PMA 2018
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.